From pharmaceutical products that must remain within a strict temperature range to high-value technology moving across ...

Halozyme Therapeutics has acquired Elektrofi, a biopharmaceutical company with a proprietary ultra-high concentration ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

A North Wales pharmaceutical manufacturer backed by the Development Bank of Wales is accelerating its global expansion by launching two new products and unveiling plans to extend its global ...

The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes extremely high levels of fat in the bloodstream, the company said on Tuesday.

A murky economic picture as government reopens, how the penny phase-out will actually work, using automation to solve mundane ...

Eli Lilly's $2.6 billion agreement with ABL Bio focuses on developing therapeutics using the Grabody Platform for bispecific ...

Pulsed field ablation sales grew by more than 300% in the second quarter for the company’s fiscal year 2026, amid mounting ...

The Rs 500-crore initial share sale will open for public subscription on November 19, with price band of Rs 114-120 per share ...

President Donald Trump is set to fete Crown Prince Mohammed bin Salman on Tuesday when the de facto leader of Saudi Arabia ...

Banks created KYC to verify customers and prevent misuse, but the real challenge often begins with customer helplines. Call ...

The past week in the world of artificial intelligence brought a mix of corporate deals, scientific progress, policy concerns, and social impact stories. The pace of change continues to pressure ...